Form 4: Tango Therapeutics General Counsel Douglas Barry Reports Acquisition of Stock Options and Restricted Stock Units

Douglas Barry, General Counsel of Tango Therapeutics, reports the acquisition of stock options and restricted stock units in the company.

Summary

• On February 3, 2025, Douglas Barry, General Counsel of Tango Therapeutics, acquired 27,363 restricted stock units (RSUs) and 164,175 stock options.
• The RSUs vest over a three-year period: 33% on February 2, 2026, 33% on February 1, 2027, and 34% on February 14, 2028, contingent upon continuous service.
• The stock options vest over a four-year period: 25% on January 1, 2026, with the remaining shares vesting in 36 equal monthly installments thereafter.
• Following these transactions, Barry directly owns 71,344 shares of common stock and 164,175 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of equity suggests confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of RSUs and stock options by a key executive signals confidence in the company's future performance.
• The vesting schedules for the RSUs and stock options incentivize long-term commitment from the General Counsel.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules suggest an expectation of continued service and company growth.

Industry Context

Stock option and RSU grants are common compensation practices in the biotechnology industry to attract and retain key personnel.

Comparison to Industry Standards

• Equity compensation packages for General Counsels in biotech companies typically include a mix of stock options and restricted stock units.
• The vesting schedules are fairly standard, aligning with industry norms for incentivizing long-term performance and retention.
• Comparable companies like Relay Therapeutics or Black Diamond Therapeutics also utilize similar equity-based compensation strategies.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign of management's commitment.
• Employees may be motivated by the alignment of executive compensation with company performance.

Key Dates

Keywords

Tango Therapeutics, Douglas Barry, stock options, restricted stock units, RSUs, Form 4, General Counsel, TNGX, beneficial ownership